Cabrera-Perez JS, Eigenmann P, Akenroye A. Editorial comment on "Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long-term safety (TATE study)". Pediatr Allergy Immunol 2024;35:e14128.
PMID: 38646955